image
Healthcare - Biotechnology - NASDAQ - US
$ 6.37
-2.9 %
$ 438 M
Market Cap
-2.3
P/E
Price Target Average
610.36%
Revenue Forecast Estimate
22.72%
EBIT Estimate
--24.00%
Net Income Estimate
53.00%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Arvinas, Inc.
image
Wall Street analysts predict an average 1-year price target for ARVN of $45.2 , with forecasts ranging from a low of $12 to a high of $70 .
ARVN Lowest Price Target Wall Street Target
12 USD 88.38%
ARVN Average Price Target Wall Street Target
45.2 USD 610.36%
ARVN Highest Price Target Wall Street Target
70 USD 998.90%
Price
Max Price Target
Min Price Target
Average Price Target
707060605050404030302020101000May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart ARVN

image
$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart ARVN

image
$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)($600.0m)($600.0m)201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart ARVN

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)($350.0m)($350.0m)($400.0m)($400.0m)201820182019201920202020202120212022202220232023202420242025202520262026202720272028202820292029